SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________ |
|
FORM 8-K |
CURRENT REPORT
|
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
|
________________ |
| |
Date of Report (Date of earliest event reported):
November 1, 2004
|
Alpharma Inc.
|
| |
(Exact name of registrant as specified in its charter) |
| |
Delaware
(State or other jurisdiction of incorporation) | 1-8593
(Commission File
Number) | 22-2095212
(IRS Employer Identification) |
| |
One Executive Drive, Fort Lee, New Jersey 07024
(Address of principal executive offices) (Zip Code) |
| |
Registrant's telephone number, including area code
(201) 947-7774 |
| |
| |
Not Applicable |
______________________________________________
(Former name or former address, if changed since |
last report) |
Item 2.02. Results of Operations and Financial Condition
On November 1, 2004, Alpharma Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2004. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statement and Exhibits
(c) Exhibits.
- Press release issued by Alpharma Inc. on November 1, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | ALPHARMA INC.
|
| | By: /s/ Matthew Farrell |
| | Matthew T. Farrell
Executive Vice President and
Chief Financial Officer |
Date: November 1, 2004
